For optimal viewing of the AACI Update click here.
News from the Association of American Cancer InstitutesMay 2015
The Association is dedicated to reducing the burden of cancer by enhancing the impact of the nation's leading academic cancer centers.
AACI Update is an e-newsletter for the cancer center directors and key contacts at AACI member institutions and individuals interested in the cancer center-related activities of AACI. AACI Update reports on the progress of AACI initiatives and other AACI endeavors that benefit the cancer community and highlights important news and events at AACI member institutions.

AACI encourages member institutions to submit cancer center highlights to AACI Update. News briefs are linked to complete stories posted on individual cancer center websites. Please e-mail materials to [email protected]. AACI reserves the right to decide whether or not materials are appropriate for inclusion.

To subscribe to AACI Update, please send an e-mail to [email protected] with your name, title, address, and telephone number asking to be added to the AACI's distribution list.

To unsubscribe from AACI Update, please send an e-mail to [email protected] with your name, title, and unsubscribe in the subject line to be removed from AACI's distribution list.


Mailing address:
3708 Fifth Avenue
Medical Arts Building, 503
Pittsburgh, PA 15213

Headlines

Knudsen Named Director of Kimmel at Jefferson
Karen E. Knudsen, PhD, has been named the Director of the Sidney Kimmel Cancer Center at Thomas Jefferson University and the Hilary Koprowski Chair of the Department of Cancer Biology of the Sidney Kimmel Medical College of Thomas Jefferson University. A leading expert in the molecular basis of hormone-dependent cancer development and progression, Dr. Knudsen focuses her work on developing new means to prevent or treat lethal prostate cancers. more...

Burr, Mikulski to Be Honored for Commitment to Cancer Community
U.S. Senators Barbara Mikulski (D-MD) and Richard Burr (R-NC) will be honored for their support of cancer research at an evening reception on May 6, the night before the annual Capitol Hill Day, in Washington, DC. This event marks the legislators' tireless work on behalf of the cancer community and will bring together many key leaders of the cancer advocacy community and esteemed scientists from across the nation.

AACI is co-hosting Hill Day on Thursday, May 7, with the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). Advocacy efforts will showcase the nation's cancer centers and how the federal investment in research sustains progress in the fight against cancer and provides economic benefits for the nation. Participants will seek to secure at least $32 billion in federal funding for the NIH for Fiscal Year (FY) 2016.

The reception honoring Senators Mikulski and Burr will take place on Wednesday, May 6, from 6:00-7:30 pm in Room B-338 of the Rayburn House Office Building in Washington. more...


AACI CRI Seeks Abstract Submissions for Annual Meeting

AACI is soliciting abstracts for presentation at the 7th Annual AACI Clinical Research Initiative Meeting that will be held on July 8-9, 2015, in Chicago, IL. The purpose of the abstract is to inform the CRI meeting audience about clinical trials operational challenges and solutions implemented at the cancer centers. The abstract due date is 5:00 PST on Monday, May 11, 2015.

Please find the meeting registration, hotel information, and preliminary program on the AACI website: www.aaci-cancer.org/cri_meeting. Please direct questions to Janie Hofacker, 412-647-6331. Potential sponsors should contact Kate Burroughs, 412-647-3844 regarding commercial support opportunities. more...

AACI CancerBlog Features Federal Budget Recommendation
Launched in early 2014, AACI CancerBlog (aacicancerblog.wordpress.com) provides another opportunity for the association to promote the work of its member centers to both general audiences and the cancer research community. The blog offers viewpoints on public policy and legislative activities that affect cancer research and care. It also covers topics of interest to its cancer center members in other areas of AACI activity.

The latest AACI CancerBlog post, "AACI Requests $32 Million for NIH Budget in FY 2016", highlights the association's government relations efforts and the need for sustained, predictable budgets for the National Institutes of Health and the National Cancer Institute. more...


AACI/CCAF Meeting Registration Reminder
Online registration continues for the 2015 AACI/CCAF Annual Meeting, to be held in Washington, DC, October 25-27. The early registration rate will remain in effect through June 8. Information on the meeting, including the program and electronic registration is available on the AACI website. more...
News from the Centers
Awards & Honors
Theodorescu Receives Barringer Medal
University of Colorado Cancer Center
Dan Theodorescu, MD, PhD, director of the NCI-designated University of Colorado Cancer Center and professor of Urology and Pharmacology at the University of Colorado School of Medicine was awarded the Barringer Medal from the American Association of Genitourinary Surgeons for his distinguished contributions to urology. more...
Clinical Research Forum Selects Genomic Analysis as Top 10 Research Achievement
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center researchers played leading roles in a cross-cancer genomics study that has been selected as one of the nation's top 10 research achievements of the year. In findings published in the journal Cell in August of 2014, researchers with The Cancer Genome Atlas network revealed a new mechanism for classifying cancers. The project was led by UNC Lineberger researchers along with scientists from other project sites collaborating as part of TCGA, a National Cancer Institute and National Human Genome Research Institute-backed effort to create a comprehensive atlas of the genetic changes in cancer. more...
Kamal Receives 2015 AAHPM's Inspirational Leaders Award
Duke Cancer Institute
The American Academy of Hospice and Palliative Medicine has named Arif Kamal, MD, a 2015 Inspirational Leader in Hospice and Palliative Medicine. Dr. Kamal is a medical oncologist and a palliative medicine specialist. His research focuses on improving the quality of care for patients who receive cancer care, supportive care services and palliative care. more...
New NCCN Member Institution: Case/Seidman and Cleveland Clinic
Case Comprehensive Cancer Center, Case Western Reserve University
The National Comprehensive Cancer Network® (NCCN®), an alliance of the world's leading cancer centers dedicated to quality, effectiveness, and efficiency of cancer care so that patients can live better lives, announced that Case Comprehensive Cancer Center which includes University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute has been elected to institutional membership. NCCN now has 26 Member Institutions serving patients throughout the United States. more...
Spiegelman Awarded European Scientific Prize
Dana-Farber Cancer Institute
Bruce Spiegelman, PhD, director of the Center for Energy Metabolism and Chronic Disease at Dana-Farber Cancer Institute, and professor of cell biology and medicine at Harvard Medical School, has received Belgium’s most important international scientific prize for his contributions to understanding the mechanisms of metabolic disorders. more...
Ellis Receives ASCO Award for Breast Cancer Genomics Research, Mentorship
The Dan L. Duncan Cancer Center
Dr. Matthew Ellis, director of the Lester and Sue Smith Breast Center at Baylor College of Medicine, has been named recipient of the 2015 American Society of Clinical Oncology's Gianni Bonadonna Breast Cancer Award and Lecture, an honor given annually to an oncologist for outstanding contributions to basic or translational research in breast cancer and exceptional mentoring abilities. more...
Schneider Elected ONS President
Duke Cancer Institute
Susan Schneider, PhD, RN, AOCN, ACNS-BC, FAAN, associate professor, Duke University School of Nursing, was recently elected as the president of the Oncology Nursing Society by the ONS board of directors. Schneider joined Duke in 2000 and currently serves as faculty lead for the graduate oncology specialty at the School of Nursing. more...
UNM Doctor Named One of AAHPM's "Inspirational Leaders Under 40"
University of New Mexico Cancer Center
The American Academy of Hospice and Palliative Medicine celebrated the outstanding work of 44 physicians throughout the country who practice palliative medicine. Esme Finlay, MD, at the University of New Mexico Cancer Center is one of them. "I think that I didn't really have even the words for palliative medicine when I was in medical school," Finlay says. Early life experiences with cancer in her family spurred her interest in the field. more...
Coffey Honored with Foti Award for Leadership and Extraordinary Achievements in Cancer Research
Sidney Kimmel Comprehensive Cancer Center
Donald S. Coffey, PhD, received the ninth annual American Association for Cancer Research (AACR) Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research at the AACR Annual Meeting 2015, in Philadelphia. Dr. Coffey, a fellow of the AACR Academy, and the Catherine Iola and J. Smith Michael distinguished professor of urology at Johns Hopkins School of Medicine in Baltimore, was honored for his tremendous leadership and profound contributions to cancer research. more...
Jaffee Receives AACR-Joseph Burchenal Award for Clinical Cancer Research
Sidney Kimmel Comprehensive Cancer Center
The American Association for Cancer Research honored Elizabeth M. Jaffee, MD, deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, with the 20th annual AACR-Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research at the AACR Annual Meeting 2015, in Philadelphia. The award was established in 1996 to recognize outstanding achievements in clinical cancer research. It is named for the late Dr. Joseph H. Burchenal, honorary member and past president of the AACR, and a major figure in clinical cancer research and chemotherapy. more...
Baltimore Honored with AACR Distinguished Lectureship
American Association for Cancer Research (AACR)
The American Association for Cancer Research (AACR) honored David Baltimore, PhD, president emeritus and Robert Andrews Millikan professor of biology at the California Institute of Technology in Pasadena, with the 11th annual AACR-Irving Weinstein Foundation Distinguished Lectureship at the AACR Annual Meeting 2015, in Philadelphia. more...
Capecchi Recognized With Lifetime Achievement in Cancer Research Award
American Association for Cancer Research (AACR)
Mario R. Capecchi, PhD, was honored for his tremendous scientific contributions, which have had a profound impact on the understanding of cancer, including his groundbreaking work in the development of gene targeting technology, with the 12th annual American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research at the AACR Annual Meeting 2015, in Philadelphia. more...
Leadership Transitions
Dana-Farber CEO Ed Benz to retire in 2016
Dana-Farber Cancer Institute
The chief executive of Dana-Farber Cancer Institute has announced that he will step down after a 16-year run that saw the specialty hospital become a fund-raising powerhouse and change from a regional center to an international destination for cancer research and treatment. Dr. Edward J. Benz Jr., Dana-Farber's longest-serving chief executive, said he will leave the job in June 2016, a month after his 70th birthday. more...
Scientist Joins Research Team at Huntsman
Huntsman Cancer Institute
Martin McMahon, PhD, joins Huntsman Cancer Institute (HCI) at the University of Utah in August as Professor in the Department of Dermatology and HCI Senior Director of Pre-Clinical Translation. Dr. McMahon is currently the Efim Guzik Distinguished Professor of Cancer Biology at the University of California, San Francisco and Assistant Director of Professional Education and Co-leader of the Helen Diller Family Comprehensive Cancer Center. more...
New President of 117-Year-Old Cancer Center Appoints New Leadership Team
Roswell Park Cancer Institute
In an effort to better align the operational structure of the century-old cancer center, Roswell Park Cancer Institute's 15th and first female president, Candace Johnson, PhD, begins her tenure by reorganizing the talent around her. more...
Zafirovski Named Associate Director for Administration
The Robert H. Lurie Comprehensive Cancer Center
Aleksandar Zafirovski, MBA, has been named Executive Administrative Director and Associate Director for Administration for the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He has served as Interim Associate Director since 2014. Zafirovski has previously been instrumental in driving the efforts that led to the successful launch and continuing expansion of the Northwestern Medicine Developmental Therapeutics Institute in the Lurie Cancer Center. more...
Research Highlights
Dual Therapy's One-Two Punch Knocks Out Drug-Resistant Lung Cancer
UCSF Helen Diller Family Comprehensive Cancer Center
Capitalizing on a rare opportunity to thoroughly analyze a tumor from a lung cancer patient who had developed resistance to targeted drug treatment, UC San Francisco scientists identified a biological escape hatch that explains the resistance, and developed a strategy in mice for shutting it down. In experiments that combined the drug the patient had taken with a second compound that blocks off this newly discovered resistance pathway, the researchers were able to durably wipe out cancer cells in mice implanted with cells from the drug-resistant tumor. more...
Statin Use Improves Renal Cell Cancer Survival
Vanderbilt-Ingram Cancer Center
A new study led by Vanderbilt University investigators found that patients being treated with statins at the time of surgery for kidney cancer, also known as renal cell carcinoma, had improved overall survival and disease-specific survival. Drugs known as statins are widely used to lower cholesterol and previous studies have indicated that they could be associated with changes in cancer outcomes. The study’s lead author was Peter Clark, MD. more...
New Genomics Tool Could Help Predict Tumor Aggressiveness, Treatment Outcomes
The Ohio State University Comprehensive Cancer Center
James Cancer Hospital & Solove Research Institute

A new method for measuring genetic variability within a tumor might one day help doctors identify patients with aggressive cancers that are more likely to resist therapy, according to a study led by researchers now at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Researchers used a new scoring method they developed called MATH (mutant-allele tumor heterogeneity) to measure the genetic variability among cancer cells within tumors from 305 patients with head and neck cancer. High MATH scores corresponded to tumors with many differences among the gene mutations present in different cancer cells. more...
Wearable Device Slows Deadly Brain Tumors, Clinical Trial Finds
University of Virginia Cancer Center
A wearable device that emits low-level electrical fields can slow the progression of glioblastoma, the deadliest form of brain cancer, and extend patients' lifespans, a major clinical trial at the School of Medicine and more than 80 other institutions has found. David Schiff, MD, of the UVA Department of Neurology, said the results of the trial have come as a "real shocker to the field," noting that glioblastoma is notoriously difficult to treat. more...
Immunotherapy Drug Shows Unprecedented Results in Advanced Lung Cancer
Jonsson Comprehensive Cancer Center, UCLA
In the largest study to date using immunotherapy to treat lung cancer, UCLA researchers have found that the drug pembrolizumab (Keytruda®), recently approved by the U.S. Food & Drug Administration to treat melanoma, is safe and effective in arresting tumor growth in patients with advanced non-small cell lung cancer. Edward Garon, MD, a member of UCLA's Jonsson Comprehensive Cancer Center, was lead author of the study. more...
Overnight Fasting May Reduce Breast Cancer Risk in Women
UC San Diego Moores Cancer Center
A decrease in the amount of time spent eating and an increase in overnight fasting reduces glucose levels and may reduce the risk of breast cancer among women, report University of California, San Diego School of Medicine researchers. Women who fasted for longer periods of time overnight had significantly better control over blood glucose concentrations. The data shows that each three hour increase in nighttime fasting was associated with a 4 percent lower postprandial glucose level, regardless of how much women ate. more...
Gene Variant Linked to Smoking Longer, Getting Lung Cancer Sooner
Siteman Cancer Center
Smokers with a specific genetic variation are more likely to keep smoking longer than those who don't have the gene variant, according to findings that may result in changes to efforts to screen patients for lung cancer. They're also more likely to be diagnosed with lung cancer at a younger age, researchers at Washington University School of Medicine in St. Louis found. more...
Study: Childhood Cancer Survivors More Likely to Be Enrolled in Social Security Support as Adults
Huntsman Cancer Institute
A new study, from Huntsman Cancer Institute (HCI) at the University of Utah, shows for the first time that childhood cancer survivors, diagnosed between 1970 and 1986, are more than five times as likely to have ever been enrolled on a federal social security disability assistance program as compared to individuals without a cancer history. Anne Kirchhoff, PhD, was lead author of the study. more...
Lower Survival Rates Connected with High-Risk Melanoma with Mutations
UNC Lineberger Comprehensive Cancer Center
Researchers from the UNC Lineberger Comprehensive Cancer Center led an analysis of hundreds of melanoma samples to find out if two genetic mutations more commonly found in melanoma tumors were associated with lower survival rates in patients. Nancy E. Thomas, MD, PhD, a UNC Lineberger member, was the study's principal investigator. more...
Researchers Develop New Potential Drug for Rare Leukemia
University of Michigan Comprehensive Cancer Center
Researchers at the University of Michigan Comprehensive Cancer Center have developed a new drug candidate that shows potential in laboratory studies against a rare type of acute leukemia. And additional studies suggest the same compound could play a role in prostate cancer treatment as well. The compound was developed in the labs of Jolanta Grembecka, PhD, and Tomasz Cierpicki, PhD, who have been working for several years to identify a small-molecule inhibitor that would block the interaction between the protein menin and MLL fusion proteins that cause a rare type of acute leukemia. more...
Drug Resistant Mechanism Revealed for a New Targeted Cancer Therapy
Rutgers Cancer Institute of New Jersey
New research from Rutgers Cancer Institute of New Jersey shines a light on identifying 'hot spots' in drug-resistant mutations. The work involves the mTOR protein - a central controller of cell growth and metabolism and a key driver of cancer. X. F. Steven Zheng, PhD, is senior author of the study. more...
UCSF Joins Lung Cancer Dream Team
UCSF Helen Diller Family Comprehensive Cancer Center
Previous HDFCCC director and long-time RAS researcher Frank McCormick, PhD, FRS, DSc (Hon), will join a group of prominent cancer research and treatment institutions in a new Stand Up To Cancer (SU2C)-American Cancer Society $20 million Dream Team to combat lung cancer.

The Lung Cancer Dream Team has devised a three-pronged approach to focus on KRAS mutant lung cancer. It includes working to define the most effective therapies to target KRAS and critical related biological pathways, targeting the immune system for the treatment of KRAS mutant lung cancers, and integrating targeted therapies with immunotherapies for these lung cancers. more...
Breakthrough Points to More Effective Treatments for HER2+ Breast Cancer
Case Comprehensive Cancer Center, Case Western Reserve University
Ahmad M. Khalil, PhD, knew the odds were against him — as in thousands upon thousands to one. Yet he and his team never wavered from their quest to identify the parts of the body responsible for revving up one of the most aggressive forms of breast cancer, HER2+. Dr. Khalil and his colleagues at Case Western Reserve University have proved the power of persistence; from a pool of more than 30,000 possibilities, they found 38 genes and molecules that most likely trigger HER2+ cancer cells to spread. more...
Getting Smokers to Quit with an Unlikely Drug: Nicotine
University of Kansas Cancer Center
Ed Ellerbeck, MD, MPH, co-leader of The University of Kansas Cancer Center’s Cancer Control and Population Health Program, and chair of the Department of Preventive Medicine and Public Health at the University of Kansas Medical Center, is studying an alternative method to quitting smoking for people who have chronic obstructive pulmonary disease without requiring them to attempt to quit abruptly. more...
Immunomagnetic Assay On-a-Chip Captures, Analyzes Circulating Tumor Cells
Dartmouth-Hitchcock Norris Cotton Cancer Center
To quantify rare tumor markers that will allow oncologists to make prognoses and select therapies, John X.J. Zhang, PhD, led a team of bioengineers from the Thayer School of Engineering at Dartmouth in demonstrating a novel system that couples nano-engineered particles and microfluidic chips for capturing and manipulating circulating tumor cells (CTCs). The microscale immunoassay can be further interfaced with a fluorescent microscope for cancer cell imaging. more...
Promising Drug a 'New Paradigm' for Treating Leukemia
University of Virginia Cancer Center
Researchers at the UVA School of Medicine have developed a compound that delays leukemia in mice and effectively kills leukemia cells in human tissue samples, raising hopes that the drug could lead to improved treatments in people. The researchers call it an exciting "new paradigm" for treating leukemia. more...
Evidence Points to Fallopian-Tube Origins of Ovarian Cancers
Fox Chase Cancer Center, Temple Health
A new surgical approach that removes the fallopian tubes while sparing the ovaries may provide premenopausal women at high risk for ovarian cancer, particularly those with BRCA1/2 mutations, with a cancer risk-minimizing surgical option that also reduces some negative effects of ovary removal at a young age, according to a review published in the May issue of Cancer Prevention Research, a journal of the American Association for Cancer Research. more...
Breast Tumor Stiffness and Metastasis Risk Linked by Molecule's Movement
UC San Diego Moores Cancer Center
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and poor prognosis. The study may inspire new approaches to predicting patient outcomes and halting tumor metastasis. Jing Yang, PhD, was senior author of the study. more...
Enzyme Cuts Path for T-cells to Fight Solid Tumors
The Dan L. Duncan Cancer Center
Chimeric antigen rector (CAR)-redirected T-cells specifically engineered to express the enzyme heparanase have an improved ability to infiltrate the extracellular matrix surrounding solid tumors - allowing the T-cells to infiltrate and shrink the tumors, said researchers from the NCI-designated Dan L. Duncan Cancer Center at Baylor College of Medicine. Dario Marchetti, PhD, was lead author of the study. more...
Frequent Indoor Tanning Shows Correlation with Smoking, Social Media Use
Rutgers Cancer Institute of New Jersey
Research from Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health shows more than a third of New Jersey high school students who engage in indoor tanning do so frequently and many would find it hard to stop the practice. The research letter, "Frequent Indoor Tanning among New Jersey High School Students", also found that frequent indoor tanners were more likely to smoke and to engage in social media activities related to indoor tanning. more...
Two Distinct Populations of CD4 T Cells Play Different Roles in Immune System
Dartmouth-Hitchcock Norris Cotton Cancer Center
Utilizing a novel transgenic mouse model, Edward Usherwood, PhD of Dartmouth's Norris Cotton Cancer Center and collaborators found that CD4 T cells divide into two different populations that each have different jobs. One type performs antiviral functions, and the other survives life in the host. The study, "Functional Heterogeneity in the CD4+ T Cell Response to Murine Y-Herpesvirus 68," was published in the Journal of Immunology. more...
Keytruda Shown to Improve Response to Tumors, Extend Life in Advanced Melanoma
Jonsson Comprehensive Cancer Center, UCLA
An international team of researchers led by Antoni Ribas, MD, and his colleagues at UCLA has found that pembrolizumab (Keytruda) was more effective in treating advanced melanoma than the current standard of care treatment, ipilimumab (Yervoy). The study found that pembrolizumab improved tumor response and duration of response, and extended the lives of people with melanoma — and with less severe side effects — than ipilimumab. more...
UNM Opens International Clinical Trial for Personalized Kidney Cancer Vaccine
University of New Mexico Cancer Center
The University of New Mexico Cancer Center recently enrolled its first patient in a phase 3 international clinical trial to test a personalized vaccine against metastatic kidney cancer. Kidney cancer has proven particularly difficult to treat with chemotherapy, and numerous attempts to create a kidney cancer vaccine have not improved survival rates. The phase 3 trial at the UNM Cancer Center tests a promising new approach: it uses a person's own kidney cancer cells to make a vaccine tailored to kill those cells. Richard Lauer, MD, FACP, is principal investigator for the trial. more...
Similarities Between Polycystic Kidney Disease, Cancer May Point to Therapeutic Options
Fox Chase Cancer Center, Temple Health
Researchers at Fox Chase Cancer Center recently conducted a review of the pathological features of a progressive inherited disease called autosomal dominant polycystic kidney disease (ADPKD). They found many similarities between ADPKD and cancer's signaling pathways and inhibitors, highlighting potential avenues for the use of existing cancer therapeutics in the treatment of ADPKD. more...
Study: Obesity Significantly Increases Prostate Cancer Risk in African-American Men
Fred Hutchinson Cancer Research Center
Obesity has a profoundly different effect on prostate cancer risk in African-American as compared to non-Hispanic white men. Obesity in black men substantially increases the risk of low- and high-grade prostate cancer, while obesity in white men moderately reduces the risk of low-grade cancer and only slightly increases the risk of high-grade cancer, according to the first large, prospective study to examine how race and obesity jointly affect prostate cancer risk. more...
Personalized Melanoma Vaccines Marshal Powerful Immune Response
Siteman Cancer Center
Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients' tumors, according to early data in a first-in-people clinical trial at Washington University School of Medicine in St. Louis. The tailor-made vaccines, given to three patients with advanced melanoma, appeared to increase the number and diversity of cancer-fighting T cells responding to the tumors. The finding is a boost to cancer immunotherapy, a treatment strategy that unleashes the immune system to seek out and destroy cancer. more...
Brain Tumor Growth can be Slowed, Study Suggests
UF Health Cancer Center
For most patients with a common brain tumor, the outlook is grim. Aggressive and stubborn, glioblastoma is hard to wipe out with surgery, radiation or chemotherapy. Now, a group that includes University of Florida Health researchers has found a way to improve survival time in a mouse model by halting the tumor's spread. It's the first time scientists have manipulated successfully the signals in a cell that allow it to contract in order to impede a brain tumor's growth. The approach makes it harder for the cell to squeeze through surrounding tissue, keeping the tumor in check. more...
Other News
  Agreement Reached with Cuban Center for Molecular Immunology
Roswell Park Cancer Institute
Empire State Development President, CEO & Commissioner Howard Zemsky and Roswell Park Cancer Institute Chief Executive Officer and President Dr. Candace Johnson have announced that following the NYS Trade Mission to Cuba, Roswell Park has signed an agreement with Cuba's Center for Molecular Immunology to develop a unique lung cancer vaccine with a clinical trial in the United States. The trade mission facilitated face-to-face connections and enabled the two parties to hammer out the final details. more...
Innovative Methods, New Technology Used to Increase HPV Vaccinations in Florida
UF Health Cancer Center
Even though a safe HPV vaccine is available that can prevent several types of cancer, less than half of American youth in the U.S. receive the vaccine. Now a team of researchers, including four from the University of Florida Institute for Child Health Policy, has increased the odds of adolescents starting the vaccine series by 140 percent among girls and 60 percent among boys. The researchers not only identified key factors that influence how likely parents are to start the vaccination series, they also implemented an innovative multipronged approach that included mailings and using new technology in primary care clinics. more...
Aetna, Moffitt Form Oncology Medical Home
Moffitt Cancer Center
Moffitt Cancer Center and Aetna have announced a collaboration to create an oncology medical home that is designed to improve the care experience for cancer patients. Within an oncology medical home model, teams of cancer specialists collectively provide for a patient's health care when he or she has a cancer diagnosis. The model will give Moffitt the responsibility to arrange for appropriate care that is continuous and proactive. more...
OSU Wexner Medical Center Accredited as ’Cancer Rehabilitation Specialty’ Program
The Ohio State University Comprehensive Cancer Center
James Cancer Hospital & Solove Research Institute

The Ohio State University Wexner Medical Center's Dodd Hall Inpatient Rehabilitation Hospital is among the first in the world to be accredited as a "Cancer Rehabilitation Specialty Program" by the Commission on Accreditation of Rehabilitation Facilities (CARF) International, an independent, nonprofit accreditor of health and human services, including medical rehabilitation. more...
Job Opportunities
Assistant Director, Cancer Center Clinical Trials Office  
University of Arizona Cancer Center, Tucson, Arizona

more...

Faculty Positions in Cancer Research  
University of Kentucky Markey Cancer Center

more...

Assistant Director, Knight Clinical Research Management  
Knight Cancer Institute, Oregon Health & Science University

more...

Manager, Application Development & HPC Systems  
Moffitt Cancer Center

more...

Vice President, Cancer Services  
Winship Cancer Institute of Emory University

more...

Revenue Cycle Administrator, Hematology/Medical Oncology   
Georgetown Lombardi Comprehensive Cancer Center

more...

Associate Director, Cancer Prevention and Control  
Virginia Commonwealth University Massey Cancer Center

more...

Meeting Announcements

7th Annual AACI Clinical Research Initiative Meeting

Register now: www.aaci-cancer.org/cri_meeting
July 8-9, 2015
The Westin O'Hare, Rosemont, IL

2015 AACI/CCAF Annual Meeting

Register now: aaci-cancer.org/annual_meeting
October 25-27, 2015
Mandarin Oriental, Washington, DC